Yahya Fahad Mohammed Jamous – författare
Visar alla böcker från författaren Yahya Fahad Mohammed Jamous. Handla med fri frakt och snabb leverans.
4 produkter
4 produkter
E-bok
Engelska, 20262 184 kr
Läs direkt efter köp
Proteomics: A Promising Approach for Cancer Research Volume 2 Proteome signaling dysregulation in cancer, therapeutic interventions, and future perspectives provides an updated overview of scientific knowledge, achievements, and findings in the field of cancer proteomics. The field of cancer proteomics is very dynamic, with emerging trends specifically related to clinical solutions. The book content was developed to help readers get up to speed on the topic and easily apply learnings into research or clinical practice.Volume 2 covers proteome signaling, their dysregulation to therapeutics options and future prospects in 17 different signaling pathways. It capitalizes the enormous interest in proteomics among academics and gives new viewpoints on this topic in cancer treatment. It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment. - Provides up to date information on current cancer proteomics research developed globally- Presents from basic research aspects to clinical implications of proteomics on cancer diagnosis and potential treatments- Discusses challenges and future developments of the field to leverage further research and applicability in clinical setting- Contains exclusive information about research on proteome signaling dysregulation in cancer and therapies globally- Includes recent details which will be the prerequisite requirement for any researcher who wants to work on cancer proteomics, proteome signaling dysregulation and therapeutics
Häftad, Engelska, 2026
1 727 kr
Skickas inom 10-15 vardagar
Proteomics: A Promising Approach for Cancer Research Volume 2 Proteome signaling dysregulation in cancer, therapeutic interventions, and future perspectives provides an updated overview of scientific knowledge, achievements, and findings in the field of cancer proteomics. The field of cancer proteomics is very dynamic, with emerging trends specifically related to clinical solutions. The book content was developed to help readers get up to speed on the topic and easily apply learnings into research or clinical practice.Volume 2 covers proteome signaling, their dysregulation to therapeutics options and future prospects in 17 different signaling pathways. It capitalizes the enormous interest in proteomics among academics and gives new viewpoints on this topic in cancer treatment. It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment.
Provides up to date information on current cancer proteomics research developed globallyPresents from basic research aspects to clinical implications of proteomics on cancer diagnosis and potential treatmentsDiscusses challenges and future developments of the field to leverage further research and applicability in clinical settingContains exclusive information about research on proteome signaling dysregulation in cancer and therapies globallyIncludes recent details which will be the prerequisite requirement for any researcher who wants to work on cancer proteomics, proteome signaling dysregulation and therapeutics- Nyhet
Häftad, Engelska, 2026
1 778 kr
Skickas inom 10-15 vardagar
Type 2 Diabetes Mellitus: Exploring Immunogenetic Pathways is a novel reference to gain a deep understanding of the genetic underpinnings and immune system dynamics in Type 2 Diabetes Mellitus (T2DM). It addresses a fundamental gap in the current literature by synthesizing complex information into accessible chapters serving as a roadmap for those needing to navigate the intricate landscape of immunogenetics. It equips readers with the tools to comprehend the underlying mechanisms, discover potential therapeutic strategies, and contribute to the ongoing dialogue in this rapidly advancing field. Real-world case studies and clinical scenarios are throughout the book to illustrate the practical applications of immunogenetics in diagnosing, treating, and managing Type 2 Diabetes Mellitus to help bridge the gap between theory and practice and enhance the relevance of the content for healthcare professionals. The book Explore the integration of multi-omics approaches, including genomics, transcriptomics, proteomics, and metabolomics, to provide a comprehensive understanding of the complex interactions between genetic and immunological factors in Type 2 Diabetes Mellitus. This holistic approach can offer insights into novel biomarkers and therapeutic targets. In addition, discussions on the ethical, legal, and social implications of immunogenetics research in Type 2 Diabetes Mellitus, such as genetic privacy, informed consent, and equity in healthcare access. Addressing these considerations is essential for promoting responsible research practices and ensuring equitable healthcare outcomes. The book is essential for seasoned researchers in T2DM, healthcare professionals, or a student entering the field; this book offers invaluable insights into the future of T2DM research and treatment.Synthesizes the latest research, providing a one-stop resource for researchers to deepen knowledge of genetic variations and immune responses in T2DM in the labIntegrates findings from diverse studies, helping researchers navigate the complexity of genetic and immune interactions in T2DMProvides insights into immune-mediated complications in T2DM and their clinical implicationsPresents case studies and practical insights for translating research findings into experimental design for personalized patient care
- Nyhet
E-bok
Engelska, 20262 249 kr
Läs direkt efter köp
Type 2 Diabetes Mellitus: Exploring Immunogenetic Pathways is a novel reference to gain a deep understanding of the genetic underpinnings and immune system dynamics in Type 2 Diabetes Mellitus (T2DM). It addresses a fundamental gap in the current literature by synthesizing complex information into accessible chapters serving as a roadmap for those needing to navigate the intricate landscape of immunogenetics. It equips readers with the tools to comprehend the underlying mechanisms, discover potential therapeutic strategies, and contribute to the ongoing dialogue in this rapidly advancing field. Real-world case studies and clinical scenarios are throughout the book to illustrate the practical applications of immunogenetics in diagnosing, treating, and managing Type 2 Diabetes Mellitus to help bridge the gap between theory and practice and enhance the relevance of the content for healthcare professionals. The book Explore the integration of multi-omics approaches, including genomics, transcriptomics, proteomics, and metabolomics, to provide a comprehensive understanding of the complex interactions between genetic and immunological factors in Type 2 Diabetes Mellitus. This holistic approach can offer insights into novel biomarkers and therapeutic targets. In addition, discussions on the ethical, legal, and social implications of immunogenetics research in Type 2 Diabetes Mellitus, such as genetic privacy, informed consent, and equity in healthcare access. Addressing these considerations is essential for promoting responsible research practices and ensuring equitable healthcare outcomes. The book is essential for seasoned researchers in T2DM, healthcare professionals, or a student entering the field; this book offers invaluable insights into the future of T2DM research and treatment. - Synthesizes the latest research, providing a one-stop resource for researchers to deepen knowledge of genetic variations and immune responses in T2DM in the lab- Integrates findings from diverse studies, helping researchers navigate the complexity of genetic and immune interactions in T2DM- Provides insights into immune-mediated complications in T2DM and their clinical implications- Presents case studies and practical insights for translating research findings into experimental design for personalized patient care